PAVmed (PAVM) Revenue Growth (3y) (2024 - 2025)
PAVmed (PAVM) Revenue Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 0.73% |
| 10 | PAVmed | 10.82 Mn | 9.28 Mn | -4,000.00 | -10.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.24% |
| Sep 30, 2025 | -59.63% |
| Mar 31, 2025 | -65.15% |
| Dec 31, 2024 | -67.82% |